ARTICLE
25 January 2019

A comparative overview of distribution and marketing of drugs across Asia-Pacific

CC
Corrs Chambers Westgarth

Contributor

With over 175 years of experience and a team of over 1000 talented professionals, we offer exceptional legal services for major transactions, projects, and disputes. Our client-focused approach and commitment to excellence ensure success for our clients. We connect with top lawyers globally for the best results.
This guide also highlights key legal and commercial issues to consider when doing business in the Asia-Pacific region.
Australia Food, Drugs, Healthcare, Life Sciences

DOWNLOAD

This Overview has been created by the Life Sciences Asia Pacific Network, of which Corrs is a member. It contains Australia-specific content by Eugenia Kolivos (Partner), Isaac Lin (Special Counsel) & Heather Curd (Senior Associate).

For many years, emerging markets have been strategically important for the growth and development of the Lifesciences sector. Almost 90% of the sector now operates in an emerging market, including the Asia-Pacific region.

The Life Sciences Asia Pacific Network has prepared this guide, which gives a comparative overview of the distribution and marketing of drugs in Australia, China, India, Indonesia, Japan, Korea, Singapore, Taiwan, Thailand and Vietnam. It also highlights the key legal and commercial issues to consider when doing business in the region.

To access a PDF copy of A Comparative overview of Distribution and Marketing of Drugs across Asia-Pacific, click the 'Download' button above.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Chambers Asia Pacific Awards 2016 Winner – Australia
Client Service Award
Employer of Choice for Gender Equality (WGEA)

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More